AVILEX PHARMA ApS: Financial statements 2017
CVR: 34896828
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,415,685 compared with DKK -5,450,675 the year before. Equity in the 2017 report amounted to DKK -8,145,579. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -2,415,685
- Equity
- DKK -8,145,579
- Total Assets
- DKK 7,252,517
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.4 mio. | -8.1 mio. | 1 |
| 2016 | - | - | -5.5 mio. | -5.7 mio. | 1 |
| 2015 | - | - | -7.6 mio. | -279 t. | 3 |
| 2014 | - | - | -1.2 mio. | -4.1 mio. | 0 |
| 2013 | - | - | -2.9 mio. | -2.9 mio. | - |
Official annual report
Keep an eye on AVILEX PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
AVILEX PHARMA ApS has published its annual report for 2016. The net result was DKK -5,450,675.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The board consists of Raymond George Hill (chair), Camilla Petrycer Hansen, Jonathan Mark Treherne and Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a net result of DKK -4,530,000 compared with DKK -4,428,000 the year before. Equity in the 2025 report amounted to DKK -10,797,000.